Drugs of abuse testing can detect the presence of illegal drugs or prescription medicines in a sample of urine, blood or hair. Screening allows the person to be referred for treatment or monitored for drug abuse/misuse. Drug testing in schools, places of employment, and in sport includes pre-employment testing, random testing, reasonable cause testing, post-accident testing, follow-up testing, and return to duty testing.
A recent report from Credence Research, Inc. predicts that the Drug of Abuse Testing/ Screening Market will reach USD 4,555.9 mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022. The market was valued at USD 3,303.4 mn in 2015.
Some of the most commonly screened drugs include Amphetamine and Methamphetamine, Barbiturates, Benzodiazepines, Marijuana, Cocaine, Methadone, and Opiates such as heroin, codeine and morphine. Based on location, the market is divided into laboratory-based screening and onsite screening.
The testing technologies used for onsite as well as laboratory testing include the immunoassay technique and the chromatography technique. Lab-based tests require trained and skilled personnel for detailed analysis, whereas onsite drugs-of-abuse testing provides immediate results and no special skills are required to perform these tests. With improvement in technology, point-of-care solutions including drug test cups are now available which ensure accurate results in a few minutes.
According to the research report, the key factors driving the growth of drug of abuse testing market are:
- Globally rising consumption of illicit drugs
- Adoption of drug of abuse (DOA) testing at the organizational level
- Increased production of illicit drugs and their trade
- Increasing death rates/road accidents due to drug abuse
The report profiles the key players in this market on the basis of characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. Major players include Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere, Inc., Abbott Laboratories, Randox Laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Sonic Healthcare and Thermo Scientific. The market is geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia-Pacific region (comprising Japan, China and India as major countries) is expected to grow at the fastest CAGR during the forecast period.